home Home Corporate Profile Drug Discovery Business Development Careers Contact Us
Select X Pharmaceuticals

Board of Directors

Claude Nash, PhD
Executive Chairman.  Formerly Chairman & CEO, Viropharma; VP for Infectious Disease and Oncology at Schering Plough Research Institute; and Head of Infectious Disease at SmithKline Beecham.

Helmut Schuehsler
Managing Partner, TVM Capital

 

Ashok Dhanrajgir
Partner and Sr. Vice President, Inventages Venture Capital


 Advisors and Consultants

Michael Chaparian, PhD

  • Founder, former CEO & Chief Scientific Officer of SelectX Pharmaceuticals 
  • Over 18 years of biotech and drug discovery experience. 
  • Formerly President & CSO of OmniScience Pharmaceuticals, President of Blue Planet Technologies, and Director of Biotechnology Development at Arizona State University.

Janette Kowalik, MBA

  • Former Director of Finance, SelectX Pharmaceuticals

  • Over 20 years finance, human resources and facilities management
  • Formerly Director of Finance & Administration OmniScience Pharmaceuticals and Vice President at Comerica Bank.

George Drusano, MD

  • Co-Director, Emerging Infections and Pharmacodynamics Laboratory, Albany Medical College

  • Co-Director and Senior Staff Scientist, Ordway Research Institute

  • Director, Clinical Pharmacology Studies Unit, Albany Medical College

  • Research Physician, Wadsworth Center, NYS Dept. of Health

Gary Zurenko, MS

  • Over 30 years experience in preclinical development and pharmacology of antimicrobials

  • Currently CSO of Micromyx

  • Formerly with Upjohn, Upjohn/Pharmacia; discovery and reg. filing team for Zyvox™, Vantin™, Cleocin™

Dean Shinabarger, PhD

  • Over 18 years of experience in antimicrobial discovery and development

  • Currently CEO of Micromyx

  • Formerly Procter & Gamble Pharma and Pharmacia; Zyvox™ development and marketing team

Arny Demain, PhD

  • Fellow, Charles A. Dana Research Institute, Drew University

  • Founder and former Head of Fermentation Microbiology at Merck & Co.

  • Former Professor of Industrial Microbiology Department, MIT

  • Member of the National Academy of Sciences

Andrew Slee, PhD

  • Over 25 years of preclinical development experience. 
  • Formerly Sr. Director Preclinical Pharmacology, Anti-infectives, Safety Pharmacology, and Cardiovascular Sciences, Dupont Pharma and Dupont Merck Pharma; VP of Pharmacology, Enanta Pharmaceuticals.



SelectX Pharmaceuticals, Inc.
607 Boylston St, LL
Boston, MA  02116
Phone: (508) 798-0216
info@selectxpharm.com

Copyright 2002-2011 by SelectX Pharmaceuticals, Inc.             
Disclaimer